Clinical Trial Update: Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 randomized multicenter trial evaluated tacrolimus for induction and maintenance therapy in lupus nephritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Kidney Diseases, Lupus Nephritis | Phase 3 | Status: COMPLETED